Lactiga
PrivateLast Round
Grant
Sep 4, 2025
Total Funding Raised
$3.61M
Company Overview
Lactiga is a biotechnology company developing novel mucosal antibodies derived from human breastmilk to address chronic disease and immune dysregulation in vulnerable populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lactiga Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Lactiga Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 4, 2025 | ||||
| Series A | Sep 4, 2025 | ||||
| Grant | Feb 3, 2025 | ||||
| Grant | Sep 21, 2022 | ||||
| Pre Seed | Sep 21, 2022 | ||||
Seed | Nov 2, 2020 |
Key People
Founding team and executive leadership
Lactiga Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Jersey Commission on Science, Innovation and Technology | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| Innovation Factory | Grant |
| 1517 Fund | Pre Seed |
| NIH RADx | Grant |
| LaunchYU | Accelerator |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2025
Received grant from National Institute of Allergy and Infectious Diseases and NIH RADx.
Lactiga Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lactiga's valuation, stock price, and market status.